Evidence map›Paper›PMID 8898357›Full record

ArticleMolecular biology of the cell1996

The membrane-cytoplasm interface of integrin alpha subunits is critical for receptor latency.

R Briesewitz, A Kern, L B Smilenov, F S David, E E Marcantonio

Abstract read
In one paragraph

Article in Molecular biology of the cell, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

R BriesewitzDepartment of Pathology, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA.
A Kern
L B Smilenov
F S David
E E Marcantonio
Columbia University · US

Funding

STRUCTURE/FUNCTION OF THE INTEGRIN ALPHA 1 BETA 1R01GM044585 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI MARCANTONIO, EUGENE E. · 1990 to 2002
$1.1M
NIGMS NIH HHS GM-44585
6 · The paper itself

Abstract

Localization of integrin receptors to focal contact sites occurs upon ligand binding. This activity is latent, since unoccupied integrin receptors do not localize to focal contacts. Deletion analysis has revealed that the alpha cytoplasmic domains is required for the maintenance of integrin receptor latency. Our current hypothesis for the mechanism of integrin post-ligand binding events is that there is a change in relationship of alpha and beta cytoplasmic domains, which overcomes receptor latency. One possible mechanism for such a change would involve the amino acid residues at the membrane-cytoplasm interface. To test this hypothesis, we have produced point mutations in the human integrin alpha 1 subunit. These mutations had no effect on the adhesion via alpha 1 beta 1 to its ligand, collagen IV. However, receptor latency is lost in one of these mutants, leading to constitutive focal contact localization. This effect did not occur in receptors with an exchange of intracellular domains, suggesting that the mechanism of loss of latency involves a relative motion of the integrin chains. These results suggest a model in which post-ligand binding events in integrin receptors are associated with changes in the position of the alpha and beta cytoplasmic domains.

Indexed as

Protein Structure, Tertiary3T3 CellsAmino Acid SequenceAnimalsAntigens, CDCell AdhesionCell MembraneCytoplasmExtracellular MatrixHumansIntegrin alpha1IntegrinsLigandsMiceMicroscopy, FluorescenceMolecular Sequence DataAntigens, CDIntegrin alpha1IntegrinsLigandsReceptors, Collagen

Identifiers

PMID8898357
PMCPMC276001
OpenAlexW2025479034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.